Adams Danielle R, Gettinger Torie, Dell Nathaniel, Cabassa Leopoldo J, Nicol Ginger E
School of Social Work, College of Health Sciences, University of Missouri-Columbia, Columbia, Missouri.
Healthy Mind Lab, Department of Psychiatry, Washington University, St. Louis, Missouri.
Mo Med. 2024 Nov-Dec;121(6):467-473.
The United States is facing a growing behavioral health crisis. Now more than ever, novel, safe and effective treatments are needed. Over the past decade, clinical trials of psychedelic-assisted psychotherapies (PAT) have shown promising results for treating a number of common behavioral health conditions with minimal adverse effects. This article provides a brief historical and sociopolitical context surrounding PAT, discusses unanswered questions related to the safety and quality of PAT, and charts a pathway forward through the complex policy, legal, and social barriers to uptake for the state of Missouri in its consideration of PAT as a behavioral health treatment. With careful consideration and proper infrastructure, PAT could represent a paradigm shift in how the field approaches the prevention, treatment, and potential recovery of behavioral health conditions. We outline how Missouri can be at the forefront of advancing the science and practice of PAT - cautiously.
美国正面临日益严重的行为健康危机。如今,对新颖、安全且有效的治疗方法的需求比以往任何时候都更为迫切。在过去十年中,迷幻剂辅助心理治疗(PAT)的临床试验已显示出在治疗多种常见行为健康状况方面取得了有前景的结果,且副作用极小。本文提供了围绕PAT的简要历史和社会政治背景,讨论了与PAT的安全性和质量相关的未解决问题,并为密苏里州在将PAT视为一种行为健康治疗方法进行考量时,绘制了一条通过复杂的政策、法律和社会障碍以实现采用的前进路径。经过仔细考量并具备适当的基础设施,PAT可能代表该领域在行为健康状况的预防、治疗及潜在康复方面的一种范式转变。我们概述了密苏里州如何能够谨慎地处于推进PAT科学与实践的前沿。